A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

ABSTRACT: This is an open-label, Phase 2, multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination with balstilimab or standard-of-care treatments in participants with refractory metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2760681 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR